JANX
USDJanux Therapeutics Inc. Common Stock
$25.110-0.100 (-0.397%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$25.210
High
$25.450
Low
$24.713
Volume
0.55M
Company Fundamentals
Market Cap
1.5B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.97M
Exchange
NGM
Currency
USD
52-Week Range
Low $22.48Current $25.110High $71.71
Related News
BusinessWire
Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates
Phase 1b expansion study initiated in taxane-naïve mCRPC patients Updated data from Phase 1a dose escalation support initiation of Phase 1b dose expansion Updates on JANX007 and JANX008 expected in the second half
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.